Initial and Final Status of the Patients with Niemann Pick A and B: Ege University Experience
dc.contributor.author | Canda, Ebru | |
dc.contributor.author | Yazici, Havva | |
dc.contributor.author | Er, Esra | |
dc.contributor.author | Ucar, Sema Kalkan | |
dc.contributor.author | Onay, Huseyin | |
dc.contributor.author | Sozmen, Eser | |
dc.contributor.author | Özkınay, Ferda | |
dc.contributor.author | Coker, Mahmut | |
dc.date.accessioned | 2019-10-27T10:42:03Z | |
dc.date.available | 2019-10-27T10:42:03Z | |
dc.date.issued | 2018 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Aim: Niemann-Pick disease (NPD) is a lysosomal storage disease caused by an insufficient activity of acid sphingomyelinase (ASM) resulting in the accumulation of sphingomyelin. Type A is an infantile neurovisceral fatal form characterized by hepatosplenomegaly and rapidly progressive neurological deterioration, while the Type B non-neuronopathic disease presents visceral form and sufferers usually survive into adulthood. Materials and Methods: Here we present clinical and molecular findings for 19 patients with NPO A/B. Results: Nineteen patients with ASM deficiency were enrolled in our study. Nine of them were female and ten patients were male. The median age of the patients was 7.5 years (minimum-maximum: 1-57 years), the median age at diagnosis was 3 years (minimum-maximum: 6 months-56 years). The median length of the follow up period was 4.07 +/- 3.8 years (range: 1 month-14years). Eighteen patients had hepatosplenomegaly, one patient had splenomegaly. Pulmonary involvement was detected in 10 patients. Six patients died during follow up. Conclusion: Patients with Niemann Pick A/B have a high mortality and morbidity rate. There is a need for a safe and effective therapy for patients with NPD A/B to reduce splenomegaly, to improve liver and respiratory function and to reduce the rate of mortality and morbidity. | en_US |
dc.identifier.doi | 10.4274/jpr.75046 | |
dc.identifier.endpage | 27 | en_US |
dc.identifier.issn | 2147-9445 | |
dc.identifier.issn | 2147-9445 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 22 | en_US |
dc.identifier.uri | https://doi.org/10.4274/jpr.75046 | |
dc.identifier.uri | https://hdl.handle.net/11454/30602 | |
dc.identifier.volume | 5 | en_US |
dc.identifier.wos | WOS:000436882600006 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Galenos Yayincilik | en_US |
dc.relation.ispartof | Journal of Pediatric Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Hepatosplenomegaly | en_US |
dc.subject | interstitial pulmonary disease | en_US |
dc.subject | cytopenia | en_US |
dc.subject | acid sphingomyelinase | en_US |
dc.title | Initial and Final Status of the Patients with Niemann Pick A and B: Ege University Experience | en_US |
dc.type | Article | en_US |